MGTA
Magenta Therapeutics Inc
Price:
0.7
USD
Volume:
376,060
United States | Biotechnology
MGTA Gross Margin
As of 2025-05-28, the Gross Margin of Magenta Therapeutics Inc (MGTA) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
MGTA Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2022-12-31 | 7775.2% |
| 2021-12-31 | - |
| 2020-12-31 | - |
| 2019-12-31 | - |
| 2018-12-31 | - |
| 2017-12-31 | - |
| 2016-12-31 | - |
| - | |
| - | |
| - |
MGTA Gross Margin - Peers Comparison